全球硫酸酯酶市場：2023-2028 年預測

硫酸酯酶市場預計在預測期內將以 6.51%的年複合成長率成長。

硫酸酯酶市場預計在預測期內將以穩定的速度成長。硫酸酯酶在硫酸鹽代謝中扮演重要角色。人體內硫酸酯酶缺乏會導致多種疾病，包括溶小體儲存障礙。不斷增加的疾病和持續的科學研究預計將推動硫酸酯酶市場的成長。此外，技術的採用和對食品安全的日益關注預計將擴大硫酸酯酶的市場規模。

製藥業不斷成長的需求

硫酸酯酶由於能夠合成活性藥物成分的中間體，因此在製藥工業中非常有用。最近，兩種抑制SARS-Cov-2的抗病毒藥物RPI-27和RPI-28源自岩藻依聚醣（一種硫酸酯酶）。在動物中，硫酸酯酶缺乏會導致先天性缺陷，例如內臟症狀、HS累積和異染缺陷。治療這些疾病需要使用硫酸酯酶，它可作為催化酶。這種在製藥業的使用帶來了巨大的好處，預計將推動硫酸酯酶市場的成長。

擴大硫酸酯酶的應用將推動市場成長

硫酸酯酶用於多種行業，包括製藥、農業、石油和化學工業、清潔劑、生物燃料生產以及造紙和紙漿工業。由於其具有去除脂肪和油污的化學特性，它用於清潔劑中。此外，它還分解環境中存在的含硫化合物和細胞溶酶體中的醣脂。在海洋環境中，磷酸酶充當生物催化劑，將豐富的硫酸化藻多醣代謝轉化為單醣，然後進入產生能量的代謝途徑。硫酸酯酶在各個領域的大量使用預計將在預測期內增加硫酸酯酶的市場規模。

農業部門需求的增加將推動成長

隨著人口的增加，對農產品的需求也隨之增加。根據聯合國糧食及農業組織預測，2050年，糧食需求將增加50%。硫酸酯酶在農業領域中用作分解土壤中存在的芳香族硫酸酯、酚類和硫酸鹽的酶。十字花科植物使用芥子油苷硫酸酯酶來保護自己免受食草動物、昆蟲和其他生物的侵害，提高產量。植物利用將芥子油苷轉化為惰性的脫硫芥子油苷的策略來對抗以葉子和莖為食的昆蟲。硫酸酯酶在農業領域的這些優勢預計將擴大硫酸酯酶的市場規模。

持續的研究和技術進步是成長背後的動力。

硫酸酯酶市場進行一些研究計劃和實驗。 Sulfatlas 是Sorbonne University開發的硫酸酯酶資料庫，於2013年發布。目前，Sulfatlas資料庫包含超過 150 萬個可用的硫酸酯酶序列。2021年10月，國家生物技術資訊中心的研究表明，腸道細菌利用黏蛋白糖蛋白需要單一的硫酸酯酶。此外，研究表明，單一硫酸酯酶對於體外和體內的聚醣利用非常重要。近年來，硫酸酯酶由於與人類代謝過程和病理學條件相關，在藥物研究、興奮劑控制分析和代謝組學中變得更加有用。硫酸酯酶在各種製程中的使用的此類研究和發現預計將推動硫酸酯酶市場的發展。

市場機會

不斷的研究和實驗以發現硫酸酯酶在各個方面的潛力，為硫酸酯酶市場創造成長機會。此外，政府投資和主要市場相關人員採用物聯網來增強硫酸酯酶產品並快速開拓市場也是硫酸酯酶市場的主要成長機會。意識的提高和健康相關問題加上發育異常案例的增加，預計將為硫酸酯酶市場提供積極的成長機會。

北美可望成為重要市場

預計北美地區將在硫酸酯酶市場中佔據很大的佔有率和顯著的佔有率。造成這一巨大佔有率的因素包括生物技術領域蛋白質工程的最新進展、其他相關技術的進步、政府資助的配合措施和研究計劃。此外，Compass Minerals、3M 和 Abbott Laboratories 等各種作物科學和醫療保健巨頭將硫酸酯酶涵蓋其生產中，也使北美成為硫酸酯酶市場的主要貢獻地區。

硫酸酯酶市場的主要企業

• Novozymes 成立於 1983年，是供應工業酵素和微生物的最大生物技術公司之一。該公司提供改變工業和消費流程的生物解決方案。該公司提供的產品有重組胰島素、CTAB、西曲溴銨和苯扎氯銨。拜耳股份公司為每位農民提供量身訂製的解決方案。透過 Aleve、Alka Seltzer、Bepanthen、Acceleron、Afrin 和 Adempas 等品牌，提供作物保護、永續農業技術和醫療保健方面的解決方案。住友化學是一家總部位於日本的公司，在基本化學品和塑膠、能源和功能材料、IT化學品、健康和作物科學以及製藥等領域提供解決方案。提供橡膠助劑、造紙樹脂、Sumikasuper LCP、醫用薄膜、Sumiploy、Sumitho L飼料添加劑等。

主要市場開拓

• 2022年 9月，華盛頓州立大學藥學院進行的研究發現了一種名為硫酸酯酶-2 的蛋白質，可用於緩解類風濕性關節炎的症狀。這項研究也為開發用於預防骨質流失、軟骨損傷和關節畸形的硫酸酯酶 2治療方法鋪平了道路。

目錄

第1章 簡介

• 市場概況
• 市場定義
• 調查範圍
• 市場區隔
• 貨幣
• 先決條件
• 基準年和預測年時間表

第2章 調查方法

• 調查資料
• 先決條件

第3章 執行摘要

• 研究亮點

第4章 市場動態

• 市場促進因素
• 市場抑制因素
• 波特五力分析
• 產業價值鏈分析

第5章 硫酸酯酶的全球市場：依功能分類

• 介紹
• 荷爾蒙調節
• 細胞分解
• 訊號傳導途徑的調節

第6章 全球硫酸酯酶市場：依應用分類

• 介紹
• 荷爾蒙依賴性癌症
• 溶小體貯積症
• 發育異常
• 細菌致病機制

第7章 全球硫酸酯酶市場：依最終用戶分類

• 介紹
• 醫院
• 門診手術中心
• 其他

第8章 全球硫酸酯酶市場：依地區

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 其他
• 中東、非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 其他
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 韓國
  • 印尼
  • 泰國
  • 其他

第9章 競爭環境及分析

• 主要企業及策略分析
• 市場佔有率分析
• 合併、收購、協議和合作

第10章 公司簡介

• Bayer AG（Germany）
• BASF SE（Germany）
• Yara International（Norway）
• Compass Minerals（US）
• Sumitomo Chemicals（Japan）
• UPL（India）
• Israel Chemical Company（Israel）
• Novozymes A/S（Denmark）
• Syngenta Crop Protection AG（Switzerland）

The global sulfatases market is estimated to grow at a CAGR of 6.51% during the forecast period.

The global sulfatases market is expected to grow at a steady pace during the forecast period. Sulfatases play a crucial role in sulfate metabolism. The deficiency of sulfatases in the human body causes various diseases including Lysosomal storage disorders. The rising diseases and continuous scientific research are anticipated to boost the sulfatases market growth. Further, the technological adoption and growing concern about food safety are supposed to propel the sulfatases market size.

Growing Need in the Pharmaceuticals Industry

The sulfatases are extremely useful in the pharmaceutical industry due to their property of synthesizing intermediates in active pharmaceutical ingredients. Recently, two anti-viral drugs RPI -27 and RPI-28 that inhibit SARS-Cov-2 were derived from fucoidans (sulfatase enzyme). There are congenital disorders occurrence in animals such as visceral manifestation, HS accumulation, and metachromatic disorders caused by deficiency of sulfatases. For the treatment of these disorders, the use of sulfatases is necessary as it acts as a catalyst enzyme. This usage in the pharmaceutical industry with phenomenal benefits is expected to boost the sulfatases market growth.

Wider Application use of these sulfatases will drive market growth

Sulfatases are used for their properties in various industries such as pharmaceutical, agriculture, oil and chemical industry, detergents, biofuel production, and paper and pulp industry. Due to its chemical property to remove fat and oil stains, it is used in detergents. Moreover, it degrades sulfur-containing compounds that are present in the environment and the degradation of glycolipids in the lysosome of cells. Sufatases act as a biocatalyst in the marine environment by metabolically transforming abundant sulfated algal polysaccharides into monosaccharides. These monosaccharides can enter energy-yielding metabolic pathways. The multiple uses of sulfatases in various sectors are contemplated to boost the sulfatase market size during the forecasted year.

Growing Demand in the Agriculture Sector will act as a growth driver

The demand for agricultural products is increasing with the growing population. According to the UN Food and Agricultural Organization, the food demand will increase by 50% by the year 2050. Sulfatases are used in the agriculture sector as an enzyme that breaks down aromatic sulfate esters phenols and sulfate present in the soil. The glucosinolate sulfatases are used by cruciferous plants to defend themselves from herbivory, insects, and other organisms thereby increasing the yield. The strategy to convert glucosinolate into inactive desulfoglucosinolates is used by plants against phloem-feeding insects. These advantages of sulfatases in the agricultural sector are supposed to propel the sulfatases market size.

Constant Research and Technological Advancements are further acting as growth drivers

Several research projects and experiments are happening in the sulfatases market. Sulfatlas is a database of sulfatases developed by Sorbonne University and released in 2013. Currently, the Sulfatlas database contains more than 1.5 lakh entries of available sulfatase sequences. In October 2021, a study by the National Centre for Biotechnology Information showed that a single sulfatase is required to utilize mucin glycoproteins by gut bacteria. Moreover, research has shown that single sulfatase is essential to utilize glycans in vitro and in vivo. Recently, sulfatases have been found to be of greater utility in the investigation of drugs, doping control analysis, and metabolomics due to their link between metabolic processes and pathophysiological conditions in humans. This research and the discovery of utilization of sulfatases in various processes are contemplated to boost the sulfatases market.

Opportunities in the market

The continuous research and experiments to discover the potential of sulfatases in all possible ways are providing growth opportunities in the sulfatases market. Moreover, the government investments and adoption of the Internet of Things by the major market players to enhance their products using sulfatases and rapid development is another major growth opportunity in the sulfatase market. The rising awareness and the health-related issues coupled with the rising cases of developmental abnormalities are further expected to provide a positive growth opportunity in the sulfatases market.

North America is expected to emerge as a significant market

The North American region is expected to contribute a major share and significant share in the global sulfatases market. Various factors attributing to the significant share are recent advancements of protein engineering in the biotechnology sector, other related technological advancements, government-backed initiatives, and research projects. Moreover, the presence of various crop science companies and healthcare leading companies such as Compass Minerals, 3M, Abbott Laboratories, and others which inculcate sulfatases in their production makes North America a major contributing region in the sulfatases market.

Sulfatases Market Key Players

• Novozymes established in 1983 is one of the largest biotechnology companies that supply industrial enzymes and microorganisms. The company provides bio-solutions that transform industrial and consumer processes. The product offered by the company is recombinant insulin, CTAB, cetrimide, and benzalkonium chloride.
• Bayer AG provides tailored solutions to each farmer. It offers crop protection, sustainable farming techniques, and healthcare solutions through Aleve, Alka Seltzer, Bepanthen, Acceleron, Afrin, Adempas, and several other brands.
• Sumitomo Chemicals is a Japan-based company that provides solutions in essential chemicals and plastics, energy and functional material, IT-related chemicals, health and crop sciences, and pharmaceuticals. The company offers rubber chemicals, paper processing resins, Sumikasuper LCP, medical films, sumiploy, Summit-L feed additives, and others.

Key Market Developments

• In September 2022, a study conducted by WSU College of Pharmacy identified a protein known as sulfatase-2 that is used to ease rheumatoid arthritis symptoms. This research also opens the way for the development of therapies with sulfatase-2 to prevent bone loss, cartilage damage, and deformed joints.

Segmentation:

By Function

• Hormone Regulation
• Cellular Degradation
• Modulation of Signalling Pathways

By Application

• Hormone-Dependent Cancers
• Lysosomal Storage Disorders
• Developmental Abnormalities
• Bacterial Pathogenesis

By End-User

• Hospitals
• Ambulatory Surgical Centres
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. GLOBAL SULFATASES MARKET BY FUNCTION

• 5.1. Introduction
• 5.2. Hormone Regulation
• 5.3. Cellular Degradation
• 5.4. Modulation of Signalling Pathways

6. GLOBAL SULFATASES MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Hormone-Dependent Cancers
• 6.3. Lysosomal Storage Disorders
• 6.4. Developmental Abnormalities
• 6.5. Bacterial Pathogenesis

7. GLOBAL SULFATASES MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Ambulatory Surgical Centres
• 7.4. Others

8. GLOBAL SULFATASES MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. The Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

• 10.1. Bayer AG (Germany)
• 10.2. BASF SE (Germany)
• 10.3. Yara International (Norway)
• 10.4. Compass Minerals (U.S.)
• 10.5. Sumitomo Chemicals (Japan)
• 10.6. UPL (India)
• 10.7. Israel Chemical Company (Israel)
• 10.8. Novozymes A/S (Denmark)
• 10.9. Syngenta Crop Protection AG (Switzerland)